100.00% -31.23

Immunogen, Inc. (IMGN)

Immunogen, Inc. Aktie (IMGN) Neueste Nachrichten

Immunogen, Inc. (IMGN)

Immunogen, Inc. Aktie (IMGN) Neueste Nachrichten

Best Momentum Stocks to Buy for January 4th - MSN

Institutional investors in ImmunoGen, Inc. (NASDAQ:IMGN) lost 9.0% last week but have reaped the benefits of longer ... - Yahoo Sport Australia

AbbVie lowers first-quarter guidance after closing acquisition ImmunoGen - MSN

ImmunoGen's ovarian cancer drug fails in late-stage study - Reuters.com

Immunogen (IMGN) Price Target Increased by 6.47% to 24.25 - MSN

An Intrinsic Calculation For ImmunoGen, Inc. (NASDAQ:IMGN) Suggests It's 47% Undervalued - Yahoo New Zealand News

Rainbows and Unicorns: ImmunoGen, Inc. (NASDAQ:IMGN) Analysts Just Became A Lot More Optimistic - Yahoo Lifestyle UK

Here's Why You Should Add ImmunoGen (IMGN) to Your Portfolio Now - Yahoo New Zealand News

ImmunoGen (IMGN) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Singapore News

ImmunoGen (IMGN) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Movies UK

ImmunoGen (IMGN) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Singapore News

ImmunoGen, Inc. Announces FDA Approval of Kadcyla (Ado-Trastuzumab Emtansine; Also Known as T-DM1) - Yahoo Movies Canada

Rainbows and Unicorns: ImmunoGen, Inc. (NASDAQ:IMGN) Analysts Just Became A Lot More Optimistic - Yahoo Movies UK

AbbVie Gets Full OK For Cancer Drug Acquired in ImmunoGen Deal - MarketWatch

AbbVie Sells $15 Billion of Bonds to Buy ImmunoGen, Cerevel - Bloomberg

AbbVie Eyes Selling at Least $13 Billion of Bonds to Fund M&A - Bloomberg

Pharmaceutical Technology - Pharmaceutical Technology

Corvus' (CRVS) Lymphoma Drug Gets Orphan Status, Stock Up

Humacyte (HUMA) Up on HAV BLA Priority Tag for Vascular Trauma

ImmunoGen Finalizes Merger, Amends Operations, and Delists Shares - TipRanks.com - TipRanks

AbbVie Completes ImmunoGen Acquisition Amidst Cautious Outlook - TipRanks.com - TipRanks

AbbVie lowers first-quarter guidance after closing acquisition ImmunoGen - MarketWatch

Ionis' (IONS) Eplontersen Gets Fast Track Tag for New Indication

Foghorn (FHTX) Jumps 55% as Lilly Takes Up FHD-909 Development

Is ImmunoGen (IMGN) Outperforming Other Medical Stocks This Year?

ImmunoGen (IMGN) Soars 5.7%: Is Further Upside Left in the Stock?

ImmunoGen Set to Merge with AbbVie, Awaiting Final Approval - TipRanks

Final Countdown: AbbVie's Imminent Closure With ImmunoGen And What It Means (NASDAQ:IMGN) - Seeking Alpha

Bristol Myers' (BMY) Opdivo Label Expansion Filings Get Accepted

JAZZ Boosts Oncology Pipeline With KRAS Inhibitor Program

REGENXBIO's (RGNX) Hunter Syndrome Study Meets Goal, Stock Up

Deciphera (DCPH) Q4 Loss Narrower Than Expected, Revenues Beat

Immunogen leads as BCI's top performer in 2023 as index ends year up 76% - BioWorld Online

AbbVie’s fourth-quarter sales top estimates despite plunging Humira revenues

Immunogen Shareholders Approve Merger with AbbVie Inc. - TipRanks.com - TipRanks

Immunogen Shareholders Approve Merger with AbbVie Inc. - TipRanks.com - TipRanks

ImmunoGen's Merger with AbbVie Awaits Shareholder Approval - TipRanks.com - TipRanks

AbbVie's Transformational 2023, Analyst Anticipates Growth in 2024 Amid Competitive Pressures

AbbVie's Transformational 2023, Analyst Anticipates Growth in 2024 Amid Competitive Pressures - Markets Insider

Should First Trust Mid Cap Core AlphaDEX ETF (FNX) Be on Your Investing Radar?

Immunogen Merges with AbbVie, Responds to Shareholder Complaints - TipRanks.com - TipRanks

Immunogen Merges with AbbVie, Responds to Shareholder Complaints - TipRanks.com - TipRanks

Is First Trust Mid Cap Core AlphaDEX ETF (FNX) a Strong ETF Right Now?

SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates ROVR, ICVX, HA, IMGN - GlobeNewswire

ImmunoGen Sued Over Alleged Omissions in AbbVie Buyout Proxy - Bloomberg Law

Should First Trust Mid Cap Growth AlphaDEX ETF (FNY) Be on Your Investing Radar?

Should JPMorgan BetaBuilders U.S. Small Cap Equity ETF (BBSC) Be on Your Investing Radar?

How ImmunoGen (IMGN) Stock Stands Out in a Strong Industry

How ImmunoGen (IMGN) Stock Stands Out in a Strong Industry - Yahoo Finance

Cramer Says This Major Healthcare Stock Is 'Ridiculously Cheap And Doing So Many Great Things'

Ähnlich wie IMGN